Skip to content

Clinical trials

Observational Recurrence trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Recurrence Phase: Observational Country / region: United Kingdom Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20143
20151
20181
20191
20201
20212
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene2
AstraZeneca1
Biogen1
City, University of London1
Lahtinen, Marika1
NHS Greater Glasgow and Clyde1
Queen Mary University of London1
Regeneron Pharmaceuticals1
University College, London1
University Hospital Birmingham1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Recurrence13
Multiple Sclerosis2
Atrial Fibrillation1
Bile Duct Neoplasms1
Breast Neoplasms1
Carcinoma, Pancreatic Ductal1
Cholangiocarcinoma1
Leukemia, Lymphocytic, Chronic, B-Cell1
Lung Neoplasms1
Lymphoma, Follicular1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.